Related Experiment Video
Updated: Mar 27, 2026

A Simple Alternative to Stereotactic Injection for Brain Specific Knockdown of miRNA
Published on: December 26, 2015
Design of Effective Primary MicroRNA Mimics With Different Basal Stem Conformations
Fiona T van den Berg1, John J Rossi2, Patrick Arbuthnot1
1Wits/SAMRC Antiviral Gene Therapy Research Unit, Department of Molecular Medicine and Haematology, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
Abstract:
Primary microRNA (pri-miRNA) mimics are important mediators of effective gene silencing and are well suited for sustained therapeutic applications. Pri-miRNA mimics are processed in the endogenous miRNA biogenesis pathway, where elements of the secondary RNA structure are crucial for efficient miRNA production. Cleavage of the pri-miRNA to a precursor miRNA (pre-miRNA) by Drosha-DGCR8 typically occurs adjacent to a basal stem of ~11 bp. However, a number of pri-miRNA structures are expected to contain slightly shorter or longer basal stems, which may be further disrupted in predicted folding of the expressed pri-miRNA sequence. We investigated the function and processing of natural and exogenous RNA guides from pri-miRNAs with various basal stems (9-13 bp), where a canonical hairpin was predicted to be well or poorly maintained in predicted structures of the expressed sequence. We have shown that RNA guides can be effectively derived from pri-miRNAs with various basal stem conformations, while predicted guide region stability can explain the function of pri-miRNA mimics, in agreement with previously proposed design principles. This study provides insight for the design of effective mimics based on naturally occurring pri-miRNAs and has identified several novel scaffolds suitable for use in gene silencing applications.
Insights
Primary microRNA (pri-miRNA) mimics are key for gene silencing therapies. Their function depends on RNA structure, particularly basal stem length, enabling effective miRNA production.
Area of Science:
- Molecular Biology
- RNA Biology
- Gene Regulation
Background:
- Primary microRNA (pri-miRNA) mimics are crucial for gene silencing and therapeutic applications.
- Efficient miRNA production relies on RNA secondary structure during biogenesis.
- Drosha-DGCR8 cleavage of pri-miRNA occurs near the basal stem, typically ~11 bp.
Purpose of the Study:
- To investigate the function and processing of RNA guides derived from pri-miRNAs with varying basal stem lengths (9-13 bp).
- To determine if pri-miRNA structure stability influences the efficacy of pri-miRNA mimics.
- To identify novel pri-miRNA scaffolds for gene silencing applications.
Main Methods:
- Analysis of natural and exogenous RNA guides from pri-miRNAs with diverse basal stem lengths.
- Prediction of RNA secondary structures and hairpin maintenance for expressed pri-miRNA sequences.
- Correlation of predicted guide region stability with pri-miRNA mimic function.
Main Results:
- RNA guides can be effectively derived from pri-miRNAs with varied basal stem conformations.
- Predicted guide region stability accurately explains pri-miRNA mimic function.
- The findings align with established design principles for pri-miRNA mimics.
Conclusions:
- Pri-miRNA mimics can be designed effectively using naturally occurring pri-miRNAs with diverse basal stem structures.
- Guide region stability is a critical factor in pri-miRNA mimic design and function.
- Several novel pri-miRNA scaffolds have been identified for gene silencing applications.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Nucleic Acid Structure
DNA Structure
DNA...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

